Compounds > 5-hydroxy-3',4',6,7-tetramethoxyflavone
Page last updated: 2024-09-04

5-hydroxy-3',4',6,7-tetramethoxyflavone and eupatorin

5-hydroxy-3',4',6,7-tetramethoxyflavone has been researched along with eupatorin in 1 studies

Compound Research Comparison

Studies
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Trials
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Recent Studies (post-2010)
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Studies
(eupatorin)		Trials
(eupatorin)		Recent Studies (post-2010) (eupatorin)
150743031

Protein Interaction Comparison

ProteinTaxonomy5-hydroxy-3',4',6,7-tetramethoxyflavone (IC50)eupatorin (IC50)
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)1.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Emami, SA; Taleghani, A; Tayarani-Najaran, Z1

Reviews

1 review(s) available for 5-hydroxy-3',4',6,7-tetramethoxyflavone and eupatorin

ArticleYear
Artemisia: a promising plant for the treatment of cancer.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal

2020